Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clear Street, (“Clear Street”, “the Company”) a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors access...
-
Ottawa, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The global genomics data analysis market size was estimated at USD 6.85 billion in 2024 and is expected to hit around USD 28.74 billion by 2034, poised to...
-
NEW YORK, NY, Oct. 30, 2025 (GLOBE NEWSWIRE) -- amika, the Brooklyn-based, B Corp-certified haircare brand that’s known for its inclusive, high-performing formulas and playful spirit, is proud to...
-
CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
-
DISCLOSURE OF REGULATORY CAPITAL REQUIREMENTS EFFECTIVE FROM 1 JANUARY 2026Press release Paris, 30 October 2025 The European Central Bank notified Societe Generale Group of the level of its Pillar 2...
-
AVAILABILITY OF THE THIRD AMENDMENT TO 2025 UNIVERSAL REGISTRATION DOCUMENT Regulated Information Paris, 30 October 2025 Societe Generale hereby informs the public that the third amendment to the...
-
Ottawa, Oct. 30, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global car t-cell therapy market size reached USD 5.51 billion in 2024 and is estimated to attain USD 146.55 billion by 2034,...
-
Lynch Syndrome (LS) is a common hereditary condition that greatly increases lifetime risk of colorectal, endometrial, urothelial and other cancersNOUS-209 is an off-the-shelf immunotherapy...
-
BOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today...
-
MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...